Ziemowit Zietkowski

Bialystok, PD, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Airway inflammation and eotaxin in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.

Airway inflammation and eotaxin in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.

Journal: Advances in medical sciences

Published: September 24, 2011

Eotaxin in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction.

Eotaxin in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction.

Journal: Respiration; international review of thoracic diseases

Published: May 25, 2010

Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.

Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.

Journal: Respiratory research

Published: March 04, 2010

Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma.

Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma.

Journal: Respiration; international review of thoracic diseases

Published: October 16, 2009

RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.

RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.

Journal: International archives of allergy and immunology

Published: September 29, 2009

Changes in high-sensitivity C-reactive protein in serum and exhaled breath condensate after intensive exercise in patients with allergic asthma.

Changes in high-sensitivity C-reactive protein in serum and exhaled breath condensate after intensive exercise in patients with allergic asthma.

Journal: International archives of allergy and immunology

Published: May 25, 2009

RANTES in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction.

RANTES in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction.

Journal: Respiration; international review of thoracic diseases

Published: April 11, 2009

Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction.

Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction.

Journal: Journal of investigational allergology & clinical immunology

Published: August 22, 2008

High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma.

High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma.

Journal: Respiratory medicine

Published: August 01, 2008

Endothelin-1 in exhaled breath condensate of stable and unstable asthma patients.

Endothelin-1 in exhaled breath condensate of stable and unstable asthma patients.

Journal: Respiratory medicine

Published: April 09, 2008

Changes in RANTES and beta-thromboglobulin after intensive exercise in patients with allergic asthma.

Changes in RANTES and beta-thromboglobulin after intensive exercise in patients with allergic asthma.

Journal: International archives of allergy and immunology

Published: December 24, 2007

RANTES in exhaled breath condensate of stable and unstable asthma patients.

RANTES in exhaled breath condensate of stable and unstable asthma patients.

Journal: Respiratory medicine

Published: December 07, 2007

Showing 1-12 of 21

Last Updated: 09/26/2026